CLK3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04264 | S21 | Sugiyama | KRT1 KRTA | MSRQFSSRSGYRSGGGFSSGsAGIINYQRRTTSSSTRRSGG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P17480 | S546 | Sugiyama | UBTF UBF UBF1 | EKLMWIKKAAEDQKRYERELsEMRAPPAATNSSKKMKFQGE |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P54105 | S102 | Sugiyama | CLNS1A CLCI ICLN | VNAKFEEEsKEPVADEEEEDsDDDVEPITEFRFVPSDKSAL |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P84103 | S95 | Sugiyama | SRSF3 SFRS3 SRP20 | RVRVELSNGEKRSRNRGPPPsWGRRPRDDYRRRSPPPRRRS |
| Q05519 | S231 | Sugiyama | SRSF11 SFRS11 | KsDTsSKEIEEAMKRVREAQsLISAAIEPDKKEEKRRHSRS |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q14152 | S1308 | Sugiyama | EIF3A EIF3S10 KIAA0139 | DLRDDRDRRGPPLRSEREEVsSWRRADDRKDDRVEERDPPR |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S895 | Sugiyama | EIF3A EIF3S10 KIAA0139 | ERRLGDssLSRKDSRWGDRDsEGtWRKGPEADsEWRRGPPE |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16643 | S255 | Sugiyama | DBN1 D0S117E | HRRKQQTLEAEEAKRRLKEQsIFGDHRDEEEEtHMKKsEsE |
| Q16643 | T267 | Sugiyama | DBN1 D0S117E | AKRRLKEQsIFGDHRDEEEEtHMKKsEsEVEEAAAIIAQRP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q4G0J3 | S285 | Sugiyama | LARP7 HDCMA18P | stEPQKQCSKKKKKRDRVEAssLPEVRTGKRKRsssEDAEs |
| Q4G0J3 | S286 | Sugiyama | LARP7 HDCMA18P | tEPQKQCSKKKKKRDRVEAssLPEVRTGKRKRsssEDAEsL |
| Q63ZY3 | S356 | Sugiyama | KANK2 ANKRD25 KIAA1518 MXRA3 SIP | PREVEVVASTAAGAPAQRAQsLEPYGtGLRALAMPGRPEsP |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | S496 | Sugiyama | FIP1L1 FIP1 RHE | DRERERTRERERERDHsPtPsVFNsDEERyRYREYAERGYE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q86X29 | S493 | Sugiyama | LSR ILDR3 LISCH | QEPAREQAGGGWRARRPRARsVDALDDLtPPstAEsGsRsP |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92995 | Y708 | GPS6|SIGNOR|PSP | USP13 ISOT3 | NWIIVHMEEPDFAEPLTMPGyGGAASAGASVFGASGLDNQP |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96EP5 | S195 | Sugiyama | DAZAP1 | FHDIMGKKVEVKRAEPRDsKsQAPGQPGAsQWGsRVVPNAA |
| Q96JP5 | S83 | Sugiyama | ZFP91 ZNF757 FKSG11 | AAAAAVSRRRKAEYPRRRRssPsARPPDVPGQQPQAAKsPs |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96QK1 | S786 | Sugiyama | VPS35 MEM3 TCCCTA00141 | INKHFHNtLEHLRLRREsPEsEGPIyEGLIL__________ |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96T37 | T568 | Sugiyama | RBM15 OTT OTT1 | LVTDAFGHRAPDPLRGARDRtPPLLYRDRDRDLYPDSDWVP |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BRS2 | S507 | Sugiyama | RIOK1 RIO1 | ENQVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDP |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BW71 | S357 | Sugiyama | HIRIP3 | EDsGKGEPTAKGSRKMARLGstsGEEsDLEREVsDsEAGGG |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BY44 | S524 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | DKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKL |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H1E3 | S204 | Sugiyama | NUCKS1 NUCKS JC7 | KGKGKVGRPTAsKAsKEKtPsPKEEDEEPEsPPEKKtstsP |
| Q9H1E3 | T202 | Sugiyama | NUCKS1 NUCKS JC7 | PVKGKGKVGRPTAsKAsKEKtPsPKEEDEEPEsPPEKKtst |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9NYF8 | S196 | Sugiyama | BCLAF1 BTF KIAA0164 | EsPLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGL |
| Q9NYF8 | S319 | Sugiyama | BCLAF1 BTF KIAA0164 | RsPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKR |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9NYV4 | S249 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | DSSKQDDsPsGAsYGQDyDLsPsRsHtssNYDsYKKsPGsT |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S323 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDKK |
| Q9UQ35 | S351 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PssPYEDKDKDKKEKsAtRPsPsPERsstGPEPPAPtPLLA |
| Q9UQ35 | S353 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPYEDKDKDKKEKsAtRPsPsPERsstGPEPPAPtPLLAER |
| Q9UQ35 | S358 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KDKDKKEKsAtRPsPsPERsstGPEPPAPtPLLAERHGGsP |
| Q9UQ35 | T359 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | DKDKKEKsAtRPsPsPERsstGPEPPAPtPLLAERHGGsPQ |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.507484e-09 | 8.601 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.452476e-08 | 7.073 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.379094e-07 | 6.860 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.543398e-07 | 6.451 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.128890e-07 | 6.384 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.029779e-07 | 6.298 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.283742e-06 | 5.368 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.997955e-06 | 5.398 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.121111e-06 | 5.147 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.685183e-06 | 5.014 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.240521e-05 | 4.906 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.297461e-05 | 4.482 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.526150e-05 | 4.258 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.496185e-05 | 4.125 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.298712e-05 | 4.081 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.158001e-05 | 4.038 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.671652e-05 | 4.014 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.051654e-04 | 3.978 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.154232e-04 | 3.938 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.427715e-04 | 3.845 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.772905e-04 | 3.751 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.126735e-04 | 3.672 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.476554e-04 | 3.606 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.106190e-04 | 3.508 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.662994e-04 | 3.436 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.862407e-04 | 3.413 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.862407e-04 | 3.413 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.026184e-04 | 3.395 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.252273e-04 | 3.371 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.252273e-04 | 3.371 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.652696e-04 | 3.332 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.652696e-04 | 3.332 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.858638e-04 | 3.232 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.858638e-04 | 3.232 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.125030e-04 | 3.213 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.502464e-04 | 3.187 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.316618e-04 | 3.136 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.066280e-04 | 3.043 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.753737e-04 | 3.011 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.682212e-04 | 3.014 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.141390e-03 | 2.943 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.170589e-03 | 2.932 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.281868e-03 | 2.892 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.281868e-03 | 2.892 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.351133e-03 | 2.869 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.407046e-03 | 2.852 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.407046e-03 | 2.852 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.460602e-03 | 2.835 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.959228e-03 | 2.708 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.973413e-03 | 2.705 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.197564e-03 | 2.658 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.333935e-03 | 2.632 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.333935e-03 | 2.632 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.442087e-03 | 2.463 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.727816e-03 | 2.429 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.581210e-03 | 2.446 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.978848e-03 | 2.400 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.227231e-03 | 2.374 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.455310e-03 | 2.351 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.529302e-03 | 2.344 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.669435e-03 | 2.331 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.669435e-03 | 2.331 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.800081e-03 | 2.319 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.057293e-03 | 2.296 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.661611e-03 | 2.247 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.698628e-03 | 2.244 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.158136e-03 | 2.211 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.559161e-03 | 2.183 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.968829e-03 | 2.157 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.044160e-03 | 2.152 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.085101e-03 | 2.150 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.751597e-03 | 2.111 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.982761e-03 | 2.098 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.982761e-03 | 2.098 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.364733e-03 | 2.078 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.006785e-03 | 2.045 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.006785e-03 | 2.045 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.487397e-03 | 2.071 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.087077e-03 | 2.042 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.091287e-03 | 2.041 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.091287e-03 | 2.041 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.004098e-02 | 1.998 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.583967e-03 | 2.018 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.010772e-02 | 1.995 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.040554e-02 | 1.983 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.121703e-02 | 1.950 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.126659e-02 | 1.948 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.155647e-02 | 1.937 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.334390e-02 | 1.875 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.418509e-02 | 1.848 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.420674e-02 | 1.848 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.420674e-02 | 1.848 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.512758e-02 | 1.820 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.609251e-02 | 1.793 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.754954e-02 | 1.756 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.901481e-02 | 1.721 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.901481e-02 | 1.721 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.901481e-02 | 1.721 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.943135e-02 | 1.711 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.889870e-02 | 1.724 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.850983e-02 | 1.733 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.681870e-02 | 1.774 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.827167e-02 | 1.738 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.901481e-02 | 1.721 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.850983e-02 | 1.733 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.931350e-02 | 1.714 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.931350e-02 | 1.714 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.837105e-02 | 1.736 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.949045e-02 | 1.710 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.002447e-02 | 1.698 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.019301e-02 | 1.695 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.370966e-02 | 1.625 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.246059e-02 | 1.649 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.237034e-02 | 1.650 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.280626e-02 | 1.642 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.226684e-02 | 1.652 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.370966e-02 | 1.625 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.200993e-02 | 1.657 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.364560e-02 | 1.626 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.178630e-02 | 1.662 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.436798e-02 | 1.613 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.447067e-02 | 1.611 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.476573e-02 | 1.606 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.577966e-02 | 1.589 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.577966e-02 | 1.589 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.690760e-02 | 1.570 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.828733e-02 | 1.548 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.850589e-02 | 1.545 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.078912e-02 | 1.512 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.965171e-02 | 1.528 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.976506e-02 | 1.526 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.197842e-02 | 1.495 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.380585e-02 | 1.471 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.382070e-02 | 1.471 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.382070e-02 | 1.471 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.406219e-02 | 1.468 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.447760e-02 | 1.462 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.968381e-02 | 1.401 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.011919e-02 | 1.397 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.086596e-02 | 1.389 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.316396e-02 | 1.365 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.491570e-02 | 1.348 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.542137e-02 | 1.343 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.542137e-02 | 1.343 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.251621e-02 | 1.371 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.475668e-02 | 1.349 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.491570e-02 | 1.348 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.634163e-02 | 1.334 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.750121e-02 | 1.323 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.750121e-02 | 1.323 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.806103e-02 | 1.318 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.902997e-02 | 1.310 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.273147e-02 | 1.278 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.273147e-02 | 1.278 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.328999e-02 | 1.273 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.381353e-02 | 1.269 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 6.164521e-02 | 1.210 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.680575e-02 | 1.246 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.791360e-02 | 1.237 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.791360e-02 | 1.237 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.985469e-02 | 1.223 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.164521e-02 | 1.210 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.680575e-02 | 1.246 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.962805e-02 | 1.225 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.222320e-02 | 1.206 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.222320e-02 | 1.206 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.222320e-02 | 1.206 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.222320e-02 | 1.206 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.222320e-02 | 1.206 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.222320e-02 | 1.206 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.296282e-02 | 1.201 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.296282e-02 | 1.201 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.372447e-02 | 1.196 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.399683e-02 | 1.194 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.575358e-02 | 1.182 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.575358e-02 | 1.182 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.575358e-02 | 1.182 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.665148e-02 | 1.176 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.749722e-02 | 1.171 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.864079e-02 | 1.163 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.261456e-02 | 1.139 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.336568e-02 | 1.135 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.866423e-02 | 1.104 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.394626e-02 | 1.131 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.109992e-02 | 1.148 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.895051e-02 | 1.103 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.895051e-02 | 1.103 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.895051e-02 | 1.103 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.922685e-02 | 1.101 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.043854e-02 | 1.095 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 8.043854e-02 | 1.095 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 8.043854e-02 | 1.095 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.526091e-02 | 1.021 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.526091e-02 | 1.021 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.526091e-02 | 1.021 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.526091e-02 | 1.021 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.526091e-02 | 1.021 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.526091e-02 | 1.021 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.526091e-02 | 1.021 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.526091e-02 | 1.021 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.526091e-02 | 1.021 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.034059e-02 | 1.044 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.034059e-02 | 1.044 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.335535e-02 | 1.030 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 8.404944e-02 | 1.075 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.953470e-02 | 1.048 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.953470e-02 | 1.048 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.522928e-02 | 1.069 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.389271e-02 | 1.076 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.404944e-02 | 1.075 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.335535e-02 | 1.030 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.992699e-02 | 1.046 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.034059e-02 | 1.044 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.349656e-02 | 1.029 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.448906e-02 | 1.025 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.469481e-02 | 1.072 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.870725e-02 | 1.052 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.858192e-02 | 1.006 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.975577e-02 | 1.001 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.006727e-01 | 0.997 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.038313e-01 | 0.984 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.048910e-01 | 0.979 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.055894e-01 | 0.976 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.062285e-01 | 0.974 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.064036e-01 | 0.973 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.089061e-01 | 0.963 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.089061e-01 | 0.963 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.090192e-01 | 0.962 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.107707e-01 | 0.956 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.108552e-01 | 0.955 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.119950e-01 | 0.951 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.143316e-01 | 0.942 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.814523e-01 | 0.741 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.814523e-01 | 0.741 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.814523e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.814523e-01 | 0.741 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.220855e-01 | 0.913 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.220855e-01 | 0.913 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.220855e-01 | 0.913 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.220855e-01 | 0.913 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.220855e-01 | 0.913 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.220855e-01 | 0.913 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.594371e-01 | 0.586 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.594371e-01 | 0.586 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.594371e-01 | 0.586 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 2.594371e-01 | 0.586 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.560393e-01 | 0.807 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.560393e-01 | 0.807 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.560393e-01 | 0.807 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.560393e-01 | 0.807 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.560393e-01 | 0.807 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.207231e-01 | 0.918 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 1.914937e-01 | 0.718 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.914937e-01 | 0.718 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.914937e-01 | 0.718 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.914937e-01 | 0.718 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.914937e-01 | 0.718 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 1.914937e-01 | 0.718 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.299963e-01 | 0.481 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.299963e-01 | 0.481 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.299963e-01 | 0.481 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.299963e-01 | 0.481 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.299963e-01 | 0.481 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.299963e-01 | 0.481 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.299963e-01 | 0.481 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.299963e-01 | 0.481 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.431386e-01 | 0.844 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.667966e-01 | 0.778 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.667966e-01 | 0.778 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.667966e-01 | 0.778 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.667966e-01 | 0.778 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.914924e-01 | 0.718 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.914924e-01 | 0.718 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.646296e-01 | 0.577 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.938365e-01 | 0.405 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.938365e-01 | 0.405 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.938365e-01 | 0.405 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.938365e-01 | 0.405 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.938365e-01 | 0.405 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.938365e-01 | 0.405 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.938365e-01 | 0.405 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.228050e-01 | 0.911 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.170269e-01 | 0.663 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.170269e-01 | 0.663 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.170269e-01 | 0.663 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.173328e-01 | 0.931 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.173328e-01 | 0.931 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.014086e-01 | 0.521 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.526221e-01 | 0.816 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.432090e-01 | 0.614 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.432090e-01 | 0.614 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.010453e-01 | 0.697 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.217136e-01 | 0.654 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.217136e-01 | 0.654 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.217136e-01 | 0.654 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.378577e-01 | 0.471 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.378577e-01 | 0.471 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.515973e-01 | 0.345 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.515973e-01 | 0.345 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.515973e-01 | 0.345 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.515973e-01 | 0.345 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.429055e-01 | 0.615 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.429055e-01 | 0.615 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.429055e-01 | 0.615 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.429055e-01 | 0.615 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.429055e-01 | 0.615 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.968055e-01 | 0.528 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.968055e-01 | 0.528 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.737061e-01 | 0.427 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.315434e-01 | 0.881 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.379144e-01 | 0.624 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.238954e-01 | 0.490 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.238954e-01 | 0.490 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.238954e-01 | 0.490 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.958127e-01 | 0.708 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.958127e-01 | 0.708 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.500575e-01 | 0.824 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.751507e-01 | 0.560 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.509852e-01 | 0.455 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.942035e-01 | 0.531 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.534783e-01 | 0.452 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.427826e-01 | 0.354 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.149808e-01 | 0.502 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.046622e-01 | 0.393 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.759142e-01 | 0.425 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.595351e-01 | 0.586 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.483729e-01 | 0.605 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.323490e-01 | 0.478 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.323490e-01 | 0.478 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.719890e-01 | 0.429 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.982772e-01 | 0.400 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.757111e-01 | 0.323 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.757111e-01 | 0.323 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.757111e-01 | 0.323 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.511397e-01 | 0.259 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.116041e-01 | 0.506 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.915621e-01 | 0.407 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.205000e-01 | 0.376 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.569638e-01 | 0.340 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.425207e-01 | 0.354 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.425207e-01 | 0.354 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.108208e-01 | 0.386 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.642826e-01 | 0.333 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.642826e-01 | 0.333 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.642826e-01 | 0.333 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.498127e-01 | 0.347 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.549706e-01 | 0.342 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.549706e-01 | 0.342 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.549706e-01 | 0.342 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.072179e-01 | 0.295 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.939187e-01 | 0.226 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.939187e-01 | 0.226 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.939187e-01 | 0.226 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.064988e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.064988e-01 | 0.295 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.669719e-01 | 0.246 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.669719e-01 | 0.246 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.669719e-01 | 0.246 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.669719e-01 | 0.246 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.549330e-01 | 0.256 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.549330e-01 | 0.256 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.429595e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.429595e-01 | 0.265 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.429595e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.429595e-01 | 0.265 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.394146e-01 | 0.268 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.344884e-01 | 0.272 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.344884e-01 | 0.272 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.517162e-01 | 0.258 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.556387e-01 | 0.255 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.556387e-01 | 0.255 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.947337e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.326230e-01 | 0.199 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.326230e-01 | 0.199 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.326230e-01 | 0.199 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.326230e-01 | 0.199 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.326230e-01 | 0.199 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.326230e-01 | 0.199 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.326230e-01 | 0.199 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.715931e-01 | 0.243 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.715931e-01 | 0.243 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.715931e-01 | 0.243 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.781003e-01 | 0.238 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.026261e-01 | 0.220 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.211396e-01 | 0.207 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.117521e-01 | 0.213 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.176760e-01 | 0.209 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.239749e-01 | 0.205 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.279781e-01 | 0.202 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.279781e-01 | 0.202 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.467831e-01 | 0.189 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.437868e-01 | 0.191 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.676403e-01 | 0.175 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.676403e-01 | 0.175 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.676403e-01 | 0.175 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.676403e-01 | 0.175 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.676403e-01 | 0.175 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.699197e-01 | 0.174 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.801378e-01 | 0.167 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.257049e-01 | 0.646 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.806403e-01 | 0.419 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.375875e-01 | 0.270 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.797076e-01 | 0.553 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.375875e-01 | 0.270 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.375875e-01 | 0.270 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.171291e-01 | 0.931 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.266572e-01 | 0.645 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.068306e-01 | 0.295 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.323490e-01 | 0.478 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.064988e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.064988e-01 | 0.295 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.597844e-01 | 0.796 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.074267e-01 | 0.295 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.472943e-01 | 0.832 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.062342e-01 | 0.296 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.686170e-01 | 0.245 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.801378e-01 | 0.167 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.402791e-01 | 0.356 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.612377e-01 | 0.180 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.841060e-01 | 0.735 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.088831e-01 | 0.680 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.757111e-01 | 0.323 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.170269e-01 | 0.663 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.517134e-01 | 0.258 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.226392e-01 | 0.374 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.419105e-01 | 0.266 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.646296e-01 | 0.577 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.205000e-01 | 0.376 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.429595e-01 | 0.265 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.014086e-01 | 0.521 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.998664e-01 | 0.699 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.295003e-01 | 0.639 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.074267e-01 | 0.295 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.549330e-01 | 0.256 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.539050e-01 | 0.184 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.388149e-01 | 0.470 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.217136e-01 | 0.654 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.509852e-01 | 0.455 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.350247e-01 | 0.475 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.072179e-01 | 0.295 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.848276e-01 | 0.733 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.054465e-01 | 0.296 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 1.667966e-01 | 0.778 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.737061e-01 | 0.427 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.977627e-01 | 0.526 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.966494e-01 | 0.528 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.172092e-01 | 0.931 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.869097e-01 | 0.231 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.915621e-01 | 0.407 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.679875e-01 | 0.572 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.549706e-01 | 0.342 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.719890e-01 | 0.429 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.669719e-01 | 0.246 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.024733e-01 | 0.694 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.907331e-01 | 0.720 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.725201e-01 | 0.429 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.725201e-01 | 0.429 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.725201e-01 | 0.429 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.725201e-01 | 0.429 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.981105e-01 | 0.526 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.594371e-01 | 0.586 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.560393e-01 | 0.807 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.560393e-01 | 0.807 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.170269e-01 | 0.663 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.014086e-01 | 0.521 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.432090e-01 | 0.614 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.515973e-01 | 0.345 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.759142e-01 | 0.425 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.524152e-01 | 0.453 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.310315e-01 | 0.365 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.757111e-01 | 0.323 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.068306e-01 | 0.295 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.777285e-01 | 0.238 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.676403e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.233363e-01 | 0.909 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.857346e-01 | 0.314 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.046622e-01 | 0.393 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.163344e-01 | 0.665 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.854554e-01 | 0.544 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.431386e-01 | 0.844 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.779460e-01 | 0.423 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.757111e-01 | 0.323 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.666331e-01 | 0.574 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.026261e-01 | 0.220 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.801378e-01 | 0.167 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.530319e-01 | 0.815 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.016027e-01 | 0.696 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.560393e-01 | 0.807 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.207231e-01 | 0.918 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.737061e-01 | 0.427 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.038571e-01 | 0.298 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.038571e-01 | 0.298 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.427826e-01 | 0.354 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.667513e-01 | 0.778 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.757111e-01 | 0.323 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.757111e-01 | 0.323 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.725201e-01 | 0.429 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.314171e-01 | 0.275 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.326230e-01 | 0.199 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.211396e-01 | 0.207 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.382023e-01 | 0.195 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.786777e-01 | 0.748 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.801378e-01 | 0.167 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.751507e-01 | 0.560 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.675982e-01 | 0.246 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.524152e-01 | 0.453 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.998664e-01 | 0.699 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.086821e-01 | 0.510 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.234076e-01 | 0.205 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.525218e-01 | 0.453 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.433620e-01 | 0.464 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.667513e-01 | 0.778 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.836244e-01 | 0.736 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.780101e-01 | 0.422 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.914937e-01 | 0.718 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.667966e-01 | 0.778 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 3.938365e-01 | 0.405 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.515973e-01 | 0.345 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.515973e-01 | 0.345 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.086821e-01 | 0.510 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.038571e-01 | 0.298 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.779460e-01 | 0.423 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.842558e-01 | 0.315 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.777589e-01 | 0.556 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.682435e-01 | 0.571 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.682435e-01 | 0.571 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.588707e-01 | 0.338 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.861973e-01 | 0.413 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.560393e-01 | 0.807 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.278552e-01 | 0.642 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.561895e-01 | 0.806 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.427826e-01 | 0.354 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.248818e-01 | 0.280 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.289290e-01 | 0.201 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.809971e-01 | 0.742 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.500575e-01 | 0.824 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.781003e-01 | 0.238 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.176760e-01 | 0.209 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.378577e-01 | 0.471 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.698127e-01 | 0.770 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.619565e-01 | 0.335 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.849669e-01 | 0.415 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.797076e-01 | 0.553 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.096543e-01 | 0.678 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.699197e-01 | 0.174 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.361641e-01 | 0.473 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.034659e-01 | 0.692 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.549706e-01 | 0.342 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.590920e-01 | 0.181 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.393600e-01 | 0.194 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.814523e-01 | 0.741 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.814523e-01 | 0.741 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.594371e-01 | 0.586 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.207231e-01 | 0.918 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.299963e-01 | 0.481 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.299963e-01 | 0.481 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.299963e-01 | 0.481 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.299963e-01 | 0.481 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.278552e-01 | 0.642 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.914924e-01 | 0.718 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.938365e-01 | 0.405 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.938365e-01 | 0.405 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.170269e-01 | 0.663 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.515973e-01 | 0.345 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.087377e-01 | 0.389 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.038571e-01 | 0.298 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.332587e-01 | 0.632 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.427826e-01 | 0.354 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.046622e-01 | 0.393 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.511397e-01 | 0.259 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.915621e-01 | 0.407 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.947337e-01 | 0.226 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.947337e-01 | 0.226 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.862358e-01 | 0.232 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.863446e-01 | 0.163 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.461958e-01 | 0.190 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.461958e-01 | 0.190 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.588596e-01 | 0.181 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.612377e-01 | 0.180 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.699197e-01 | 0.174 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.419004e-01 | 0.616 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.750045e-01 | 0.171 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.823492e-01 | 0.739 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.366262e-01 | 0.360 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.442924e-01 | 0.191 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.124438e-01 | 0.673 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.561895e-01 | 0.806 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.046622e-01 | 0.393 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.110868e-01 | 0.386 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.238469e-01 | 0.650 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.678349e-01 | 0.246 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.415517e-01 | 0.193 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.415517e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.698581e-01 | 0.569 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 5.549330e-01 | 0.256 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.096543e-01 | 0.678 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.350247e-01 | 0.475 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.637904e-01 | 0.439 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.082940e-01 | 0.681 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.255299e-01 | 0.901 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.415666e-01 | 0.266 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.211396e-01 | 0.207 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.461958e-01 | 0.190 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.480226e-01 | 0.458 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.207231e-01 | 0.918 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.378577e-01 | 0.471 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.645257e-01 | 0.578 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.500575e-01 | 0.824 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.509852e-01 | 0.455 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.807348e-01 | 0.552 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.982772e-01 | 0.400 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.676403e-01 | 0.175 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.773119e-01 | 0.239 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.415517e-01 | 0.193 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.639375e-01 | 0.578 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.073354e-01 | 0.512 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.260129e-01 | 0.279 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.048742e-01 | 0.689 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.068306e-01 | 0.295 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.699197e-01 | 0.174 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 1.914937e-01 | 0.718 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 1.914937e-01 | 0.718 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.914937e-01 | 0.718 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.515973e-01 | 0.345 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.650436e-01 | 0.782 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.511397e-01 | 0.259 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.689319e-01 | 0.329 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.904429e-01 | 0.309 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.477960e-01 | 0.261 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.326230e-01 | 0.199 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.029995e-01 | 0.220 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.676403e-01 | 0.175 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.461958e-01 | 0.190 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.461958e-01 | 0.190 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.569638e-01 | 0.340 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.646296e-01 | 0.577 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.698581e-01 | 0.569 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.757111e-01 | 0.323 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.425207e-01 | 0.354 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.342431e-01 | 0.198 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.415408e-01 | 0.193 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.801378e-01 | 0.167 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.072179e-01 | 0.295 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.210503e-01 | 0.207 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.431386e-01 | 0.844 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.781003e-01 | 0.238 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.759142e-01 | 0.425 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.373543e-01 | 0.862 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.255299e-01 | 0.901 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.431457e-01 | 0.844 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.938365e-01 | 0.405 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.698581e-01 | 0.569 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.515973e-01 | 0.345 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.566593e-01 | 0.805 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.998664e-01 | 0.699 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.737061e-01 | 0.427 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.238954e-01 | 0.490 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.509852e-01 | 0.455 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.038571e-01 | 0.298 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.427826e-01 | 0.354 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.511397e-01 | 0.259 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.849669e-01 | 0.415 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.378616e-01 | 0.269 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.275297e-01 | 0.278 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.477960e-01 | 0.261 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.947337e-01 | 0.226 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.326230e-01 | 0.199 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.326230e-01 | 0.199 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.210503e-01 | 0.207 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.415408e-01 | 0.193 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.676403e-01 | 0.175 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.801378e-01 | 0.167 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.126892e-01 | 0.213 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.847661e-01 | 0.546 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.305178e-01 | 0.366 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.223704e-01 | 0.282 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.034659e-01 | 0.692 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.486091e-01 | 0.604 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.997747e-01 | 0.222 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.279781e-01 | 0.202 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.498281e-01 | 0.456 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.737061e-01 | 0.427 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.669719e-01 | 0.246 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.938632e-01 | 0.226 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.582284e-01 | 0.588 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.490535e-01 | 0.188 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.278552e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.698581e-01 | 0.569 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.310315e-01 | 0.365 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.110868e-01 | 0.386 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.607501e-01 | 0.251 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.549706e-01 | 0.342 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.779460e-01 | 0.423 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.719890e-01 | 0.429 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.878385e-01 | 0.312 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.378577e-01 | 0.471 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.515973e-01 | 0.345 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.238954e-01 | 0.490 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.038571e-01 | 0.298 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.427826e-01 | 0.354 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.511397e-01 | 0.259 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.074267e-01 | 0.295 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 5.939187e-01 | 0.226 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.939187e-01 | 0.226 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.126892e-01 | 0.213 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.676403e-01 | 0.175 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.676403e-01 | 0.175 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.699197e-01 | 0.174 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.026261e-01 | 0.220 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.205000e-01 | 0.376 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.607065e-01 | 0.251 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.415408e-01 | 0.193 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.238954e-01 | 0.490 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.823815e-01 | 0.317 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.552187e-01 | 0.256 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.008939e-01 | 0.697 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.857346e-01 | 0.314 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.685590e-01 | 0.773 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.698581e-01 | 0.569 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.134871e-01 | 0.504 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.211396e-01 | 0.207 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.534574e-01 | 0.814 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.375873e-01 | 0.359 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.971005e-01 | 0.705 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.526221e-01 | 0.816 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.086821e-01 | 0.510 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.149808e-01 | 0.502 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.626751e-01 | 0.250 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.314171e-01 | 0.275 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.480989e-01 | 0.605 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.147410e-01 | 0.288 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.560393e-01 | 0.807 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.014086e-01 | 0.521 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.779460e-01 | 0.423 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.939187e-01 | 0.226 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.326230e-01 | 0.199 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.997747e-01 | 0.222 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.608213e-01 | 0.180 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.689319e-01 | 0.329 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.642826e-01 | 0.333 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.878308e-01 | 0.163 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.010453e-01 | 0.697 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.951213e-01 | 0.225 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.951213e-01 | 0.225 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.170269e-01 | 0.663 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.194302e-01 | 0.659 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.064988e-01 | 0.295 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.698581e-01 | 0.569 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.046622e-01 | 0.393 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.719890e-01 | 0.429 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.612377e-01 | 0.180 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.087377e-01 | 0.389 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.534783e-01 | 0.452 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.534783e-01 | 0.452 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.038571e-01 | 0.298 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.205000e-01 | 0.376 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.361641e-01 | 0.473 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.997747e-01 | 0.222 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.823815e-01 | 0.317 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.699197e-01 | 0.174 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.737061e-01 | 0.427 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.326865e-01 | 0.274 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.561895e-01 | 0.806 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.699197e-01 | 0.174 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.046622e-01 | 0.393 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.314171e-01 | 0.275 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.894656e-01 | 0.161 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.911631e-01 | 0.160 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.923376e-01 | 0.160 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.923376e-01 | 0.160 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.972214e-01 | 0.157 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.982427e-01 | 0.156 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.982427e-01 | 0.156 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.982427e-01 | 0.156 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.993218e-01 | 0.155 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.993218e-01 | 0.155 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.993218e-01 | 0.155 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.993218e-01 | 0.155 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.993218e-01 | 0.155 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.993218e-01 | 0.155 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.993218e-01 | 0.155 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.993218e-01 | 0.155 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.133858e-01 | 0.147 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.134828e-01 | 0.147 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.134828e-01 | 0.147 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.134828e-01 | 0.147 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.134828e-01 | 0.147 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.134828e-01 | 0.147 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.155584e-01 | 0.145 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.155584e-01 | 0.145 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.161778e-01 | 0.145 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.162906e-01 | 0.145 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.184054e-01 | 0.144 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.229984e-01 | 0.141 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.229984e-01 | 0.141 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.235383e-01 | 0.141 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.279850e-01 | 0.138 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.279850e-01 | 0.138 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.279850e-01 | 0.138 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.279850e-01 | 0.138 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.279850e-01 | 0.138 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.279850e-01 | 0.138 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.279850e-01 | 0.138 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.279850e-01 | 0.138 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.279850e-01 | 0.138 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.333943e-01 | 0.135 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.333943e-01 | 0.135 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.333943e-01 | 0.135 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.333943e-01 | 0.135 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.333943e-01 | 0.135 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.333943e-01 | 0.135 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.333943e-01 | 0.135 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.374654e-01 | 0.132 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.375180e-01 | 0.132 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.418529e-01 | 0.130 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.421700e-01 | 0.129 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.421700e-01 | 0.129 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.452461e-01 | 0.128 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.478627e-01 | 0.126 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.478627e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.499057e-01 | 0.125 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.499057e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.521151e-01 | 0.124 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.521151e-01 | 0.124 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.521151e-01 | 0.124 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.521151e-01 | 0.124 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.538304e-01 | 0.123 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.539173e-01 | 0.123 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.539173e-01 | 0.123 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.539173e-01 | 0.123 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.539173e-01 | 0.123 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.539173e-01 | 0.123 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.539173e-01 | 0.123 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.539173e-01 | 0.123 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.539173e-01 | 0.123 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.539173e-01 | 0.123 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.539173e-01 | 0.123 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.539173e-01 | 0.123 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.539173e-01 | 0.123 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.539173e-01 | 0.123 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.539173e-01 | 0.123 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.539173e-01 | 0.123 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.590274e-01 | 0.120 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.600956e-01 | 0.119 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.628791e-01 | 0.118 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.631033e-01 | 0.117 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.661664e-01 | 0.116 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.662689e-01 | 0.116 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.668652e-01 | 0.115 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.696912e-01 | 0.114 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.696912e-01 | 0.114 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.696912e-01 | 0.114 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.696912e-01 | 0.114 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.696912e-01 | 0.114 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.696912e-01 | 0.114 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.708168e-01 | 0.113 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.724344e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.754005e-01 | 0.110 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.757520e-01 | 0.110 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.760375e-01 | 0.110 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.771610e-01 | 0.109 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.771610e-01 | 0.109 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.771610e-01 | 0.109 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.771610e-01 | 0.109 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.773787e-01 | 0.109 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.773787e-01 | 0.109 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.773787e-01 | 0.109 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.773787e-01 | 0.109 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.773787e-01 | 0.109 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.773787e-01 | 0.109 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.773787e-01 | 0.109 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.773787e-01 | 0.109 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.815706e-01 | 0.107 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.861705e-01 | 0.104 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.861705e-01 | 0.104 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.861705e-01 | 0.104 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.861705e-01 | 0.104 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.861705e-01 | 0.104 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.907275e-01 | 0.102 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.907275e-01 | 0.102 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.907275e-01 | 0.102 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.912294e-01 | 0.102 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.948488e-01 | 0.100 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.957782e-01 | 0.099 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.986046e-01 | 0.098 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.986046e-01 | 0.098 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.986046e-01 | 0.098 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.986046e-01 | 0.098 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.986046e-01 | 0.098 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.986046e-01 | 0.098 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 7.986046e-01 | 0.098 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 7.986046e-01 | 0.098 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.986046e-01 | 0.098 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.986046e-01 | 0.098 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.986046e-01 | 0.098 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.986046e-01 | 0.098 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.986046e-01 | 0.098 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.986046e-01 | 0.098 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.986046e-01 | 0.098 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.991523e-01 | 0.097 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.994422e-01 | 0.097 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.994422e-01 | 0.097 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.009000e-01 | 0.096 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.016026e-01 | 0.096 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.016026e-01 | 0.096 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.016026e-01 | 0.096 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.016026e-01 | 0.096 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.016026e-01 | 0.096 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.016026e-01 | 0.096 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.035995e-01 | 0.095 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.035995e-01 | 0.095 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.035995e-01 | 0.095 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.035995e-01 | 0.095 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.035995e-01 | 0.095 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.057518e-01 | 0.094 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.081993e-01 | 0.092 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.102201e-01 | 0.091 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.102201e-01 | 0.091 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.157989e-01 | 0.088 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.157989e-01 | 0.088 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.157989e-01 | 0.088 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.160371e-01 | 0.088 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.160371e-01 | 0.088 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.160371e-01 | 0.088 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.178079e-01 | 0.087 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.178079e-01 | 0.087 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.178079e-01 | 0.087 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.178079e-01 | 0.087 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.178079e-01 | 0.087 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.178079e-01 | 0.087 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.178079e-01 | 0.087 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.178079e-01 | 0.087 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.189730e-01 | 0.087 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.191951e-01 | 0.087 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.225764e-01 | 0.085 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.264524e-01 | 0.083 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.273485e-01 | 0.082 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.282768e-01 | 0.082 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.294727e-01 | 0.081 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.295240e-01 | 0.081 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.295240e-01 | 0.081 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.295240e-01 | 0.081 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.295240e-01 | 0.081 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.295240e-01 | 0.081 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.295240e-01 | 0.081 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.295240e-01 | 0.081 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.311357e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.311357e-01 | 0.080 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.351811e-01 | 0.078 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.351811e-01 | 0.078 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.351811e-01 | 0.078 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.351811e-01 | 0.078 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 8.351811e-01 | 0.078 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 8.351811e-01 | 0.078 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 8.351811e-01 | 0.078 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.351811e-01 | 0.078 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.351811e-01 | 0.078 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.351811e-01 | 0.078 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.351811e-01 | 0.078 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.351811e-01 | 0.078 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.351811e-01 | 0.078 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.351811e-01 | 0.078 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.356365e-01 | 0.078 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.371883e-01 | 0.077 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.407285e-01 | 0.075 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.421126e-01 | 0.075 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.421126e-01 | 0.075 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.476174e-01 | 0.072 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.485931e-01 | 0.071 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.485931e-01 | 0.071 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.508986e-01 | 0.070 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.508986e-01 | 0.070 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.508986e-01 | 0.070 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.508986e-01 | 0.070 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.508986e-01 | 0.070 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.508986e-01 | 0.070 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.508986e-01 | 0.070 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.508986e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.508986e-01 | 0.070 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.508986e-01 | 0.070 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.508986e-01 | 0.070 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.508986e-01 | 0.070 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.508986e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.508986e-01 | 0.070 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.508986e-01 | 0.070 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.508986e-01 | 0.070 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.512945e-01 | 0.070 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.518861e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.518861e-01 | 0.070 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.518861e-01 | 0.070 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.538517e-01 | 0.069 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.538517e-01 | 0.069 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.538517e-01 | 0.069 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.538517e-01 | 0.069 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.538517e-01 | 0.069 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.582219e-01 | 0.066 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.583360e-01 | 0.066 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.583360e-01 | 0.066 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.583360e-01 | 0.066 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.585427e-01 | 0.066 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.585427e-01 | 0.066 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.647887e-01 | 0.063 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.647887e-01 | 0.063 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.647887e-01 | 0.063 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.651181e-01 | 0.063 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.651181e-01 | 0.063 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.651181e-01 | 0.063 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.651181e-01 | 0.063 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.651181e-01 | 0.063 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.651181e-01 | 0.063 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.667939e-01 | 0.062 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.691086e-01 | 0.061 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.729162e-01 | 0.059 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.749698e-01 | 0.058 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.761839e-01 | 0.057 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.761839e-01 | 0.057 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.761839e-01 | 0.057 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.774300e-01 | 0.057 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.779823e-01 | 0.057 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.779823e-01 | 0.057 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.779823e-01 | 0.057 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 8.779823e-01 | 0.057 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.779823e-01 | 0.057 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.779823e-01 | 0.057 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 8.779823e-01 | 0.057 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 8.779823e-01 | 0.057 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.779823e-01 | 0.057 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.779823e-01 | 0.057 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.820610e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.820610e-01 | 0.055 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.843367e-01 | 0.053 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.844397e-01 | 0.053 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.844397e-01 | 0.053 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.860780e-01 | 0.053 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.877719e-01 | 0.052 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.896202e-01 | 0.051 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.896202e-01 | 0.051 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.896202e-01 | 0.051 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.896202e-01 | 0.051 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.896202e-01 | 0.051 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.920070e-01 | 0.050 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.920070e-01 | 0.050 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.920070e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.923443e-01 | 0.049 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.929874e-01 | 0.049 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.932413e-01 | 0.049 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.932413e-01 | 0.049 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.944766e-01 | 0.048 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.952066e-01 | 0.048 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.955733e-01 | 0.048 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.955733e-01 | 0.048 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.955733e-01 | 0.048 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.957827e-01 | 0.048 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.959335e-01 | 0.048 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.992179e-01 | 0.046 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.992179e-01 | 0.046 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.996855e-01 | 0.046 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.001488e-01 | 0.046 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.001488e-01 | 0.046 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.001488e-01 | 0.046 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.001488e-01 | 0.046 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.001488e-01 | 0.046 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.001488e-01 | 0.046 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.001488e-01 | 0.046 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.001488e-01 | 0.046 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.001488e-01 | 0.046 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.001488e-01 | 0.046 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.013853e-01 | 0.045 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.014160e-01 | 0.045 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.014160e-01 | 0.045 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.015001e-01 | 0.045 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.021019e-01 | 0.045 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.059917e-01 | 0.043 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.090033e-01 | 0.041 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.096736e-01 | 0.041 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.096736e-01 | 0.041 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.096736e-01 | 0.041 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.096736e-01 | 0.041 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.096736e-01 | 0.041 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.096736e-01 | 0.041 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.096736e-01 | 0.041 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.096736e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.096736e-01 | 0.041 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.097929e-01 | 0.041 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.118600e-01 | 0.040 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.122591e-01 | 0.040 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.123507e-01 | 0.040 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.134700e-01 | 0.039 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.134700e-01 | 0.039 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.134700e-01 | 0.039 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.137318e-01 | 0.039 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.137318e-01 | 0.039 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.140183e-01 | 0.039 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.146481e-01 | 0.039 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.146481e-01 | 0.039 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.160407e-01 | 0.038 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.160407e-01 | 0.038 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.161086e-01 | 0.038 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.170908e-01 | 0.038 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.172763e-01 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.182904e-01 | 0.037 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.182904e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.182904e-01 | 0.037 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.183160e-01 | 0.037 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.225641e-01 | 0.035 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.239085e-01 | 0.034 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.239085e-01 | 0.034 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.239085e-01 | 0.034 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.241129e-01 | 0.034 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.241129e-01 | 0.034 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.241129e-01 | 0.034 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.243411e-01 | 0.034 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.260450e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.260450e-01 | 0.033 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.260857e-01 | 0.033 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.260857e-01 | 0.033 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.260857e-01 | 0.033 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.260857e-01 | 0.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.260857e-01 | 0.033 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.260857e-01 | 0.033 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.260857e-01 | 0.033 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.260857e-01 | 0.033 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.286076e-01 | 0.032 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.286076e-01 | 0.032 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.286076e-01 | 0.032 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.313891e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.313891e-01 | 0.031 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.331376e-01 | 0.030 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.331376e-01 | 0.030 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.331376e-01 | 0.030 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.331376e-01 | 0.030 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.331376e-01 | 0.030 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.331376e-01 | 0.030 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.342032e-01 | 0.030 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.342032e-01 | 0.030 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.342032e-01 | 0.030 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.386448e-01 | 0.027 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.386448e-01 | 0.027 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.386448e-01 | 0.027 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.387438e-01 | 0.027 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.393815e-01 | 0.027 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.395172e-01 | 0.027 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.395172e-01 | 0.027 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.395172e-01 | 0.027 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.395172e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.395172e-01 | 0.027 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.395172e-01 | 0.027 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.395172e-01 | 0.027 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.407612e-01 | 0.027 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.415680e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.422732e-01 | 0.026 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.426625e-01 | 0.026 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.441710e-01 | 0.025 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.441710e-01 | 0.025 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.441710e-01 | 0.025 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.441710e-01 | 0.025 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.452884e-01 | 0.024 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.452884e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.452884e-01 | 0.024 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.452884e-01 | 0.024 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.452884e-01 | 0.024 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.452884e-01 | 0.024 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.453180e-01 | 0.024 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.469090e-01 | 0.024 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.482653e-01 | 0.023 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.485988e-01 | 0.023 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.485988e-01 | 0.023 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.485988e-01 | 0.023 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.485988e-01 | 0.023 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.505092e-01 | 0.022 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.505092e-01 | 0.022 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.505092e-01 | 0.022 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.505092e-01 | 0.022 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.507009e-01 | 0.022 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.521325e-01 | 0.021 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.521588e-01 | 0.021 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.521650e-01 | 0.021 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.521650e-01 | 0.021 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.526903e-01 | 0.021 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.526903e-01 | 0.021 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.534063e-01 | 0.021 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.552321e-01 | 0.020 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.552321e-01 | 0.020 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.552321e-01 | 0.020 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.552321e-01 | 0.020 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.552321e-01 | 0.020 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.552321e-01 | 0.020 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.552321e-01 | 0.020 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.552476e-01 | 0.020 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.564694e-01 | 0.019 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.564694e-01 | 0.019 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.564694e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.564694e-01 | 0.019 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.564694e-01 | 0.019 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.574689e-01 | 0.019 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.582151e-01 | 0.019 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.595045e-01 | 0.018 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.595045e-01 | 0.018 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.595045e-01 | 0.018 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.598601e-01 | 0.018 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.598601e-01 | 0.018 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.599583e-01 | 0.018 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.628457e-01 | 0.016 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.631781e-01 | 0.016 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.633581e-01 | 0.016 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.633581e-01 | 0.016 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.633695e-01 | 0.016 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.633695e-01 | 0.016 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.633695e-01 | 0.016 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.633695e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.633695e-01 | 0.016 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.633695e-01 | 0.016 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.633695e-01 | 0.016 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.633695e-01 | 0.016 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.633695e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.633695e-01 | 0.016 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.633695e-01 | 0.016 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.633695e-01 | 0.016 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.635507e-01 | 0.016 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.641868e-01 | 0.016 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.641868e-01 | 0.016 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.658636e-01 | 0.015 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.659744e-01 | 0.015 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.660063e-01 | 0.015 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.661482e-01 | 0.015 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.661482e-01 | 0.015 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.661482e-01 | 0.015 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.668657e-01 | 0.015 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.668657e-01 | 0.015 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.668657e-01 | 0.015 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.669208e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.679901e-01 | 0.014 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.683328e-01 | 0.014 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.684732e-01 | 0.014 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.688468e-01 | 0.014 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.688468e-01 | 0.014 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.688871e-01 | 0.014 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.688871e-01 | 0.014 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.688871e-01 | 0.014 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.688871e-01 | 0.014 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.700285e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.700285e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.700285e-01 | 0.013 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.700285e-01 | 0.013 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.700285e-01 | 0.013 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.703678e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.714118e-01 | 0.013 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.728895e-01 | 0.012 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.737382e-01 | 0.012 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.737382e-01 | 0.012 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.744902e-01 | 0.011 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.747239e-01 | 0.011 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.747452e-01 | 0.011 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.747452e-01 | 0.011 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.748185e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.748185e-01 | 0.011 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.754776e-01 | 0.011 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.754776e-01 | 0.011 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.754776e-01 | 0.011 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.754776e-01 | 0.011 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.754776e-01 | 0.011 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.756517e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.758811e-01 | 0.011 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.758811e-01 | 0.011 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.763218e-01 | 0.010 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.763841e-01 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.764245e-01 | 0.010 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.774883e-01 | 0.010 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.778187e-01 | 0.010 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.778187e-01 | 0.010 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.778544e-01 | 0.010 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.783902e-01 | 0.009 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.796709e-01 | 0.009 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.799365e-01 | 0.009 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.799365e-01 | 0.009 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.799365e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.800642e-01 | 0.009 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.801494e-01 | 0.009 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.801494e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.801494e-01 | 0.009 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.801494e-01 | 0.009 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.805785e-01 | 0.009 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.813426e-01 | 0.008 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.813426e-01 | 0.008 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.813426e-01 | 0.008 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.815485e-01 | 0.008 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.818522e-01 | 0.008 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.818522e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.818522e-01 | 0.008 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.818522e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.818522e-01 | 0.008 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.819399e-01 | 0.008 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.824962e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.828805e-01 | 0.007 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.828805e-01 | 0.007 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.831897e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.835850e-01 | 0.007 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.835850e-01 | 0.007 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.835850e-01 | 0.007 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.835850e-01 | 0.007 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.835850e-01 | 0.007 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.835850e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.835850e-01 | 0.007 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.835850e-01 | 0.007 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.835850e-01 | 0.007 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.835850e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.842064e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.842064e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.842193e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.842193e-01 | 0.007 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.842949e-01 | 0.007 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.842949e-01 | 0.007 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.851525e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.851525e-01 | 0.006 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.851525e-01 | 0.006 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.851525e-01 | 0.006 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.854507e-01 | 0.006 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.855885e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.855955e-01 | 0.006 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.863095e-01 | 0.006 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.865704e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.865704e-01 | 0.006 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.865704e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.865704e-01 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.871364e-01 | 0.006 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.877110e-01 | 0.005 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.878530e-01 | 0.005 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.878530e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.878530e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.878530e-01 | 0.005 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.878895e-01 | 0.005 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.883080e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.888784e-01 | 0.005 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.888988e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.890132e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.891353e-01 | 0.005 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.893413e-01 | 0.005 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.898259e-01 | 0.004 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.900626e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.900626e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.900626e-01 | 0.004 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.906252e-01 | 0.004 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.910118e-01 | 0.004 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.910118e-01 | 0.004 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.910118e-01 | 0.004 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.910374e-01 | 0.004 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.910943e-01 | 0.004 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.914448e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.914588e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.915106e-01 | 0.004 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.916049e-01 | 0.004 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.918704e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.918704e-01 | 0.004 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.918704e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.918704e-01 | 0.004 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.921585e-01 | 0.003 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.922148e-01 | 0.003 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.923624e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.924992e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.926230e-01 | 0.003 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.926470e-01 | 0.003 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.926470e-01 | 0.003 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.926470e-01 | 0.003 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.928346e-01 | 0.003 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.928346e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.928346e-01 | 0.003 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.928479e-01 | 0.003 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.932704e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.933495e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.933495e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.933495e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.933495e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.933495e-01 | 0.003 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.935428e-01 | 0.003 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.935428e-01 | 0.003 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.939849e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.939849e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.939849e-01 | 0.003 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.939926e-01 | 0.003 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.939926e-01 | 0.003 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.944659e-01 | 0.002 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.945007e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.945597e-01 | 0.002 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.945597e-01 | 0.002 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.946755e-01 | 0.002 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.949243e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.949666e-01 | 0.002 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.950795e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.950795e-01 | 0.002 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.950795e-01 | 0.002 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.950795e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.950795e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.950795e-01 | 0.002 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.950795e-01 | 0.002 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.952258e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.953470e-01 | 0.002 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.955497e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.955497e-01 | 0.002 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.955497e-01 | 0.002 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.955497e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.955766e-01 | 0.002 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.955766e-01 | 0.002 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.955991e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.959750e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.961440e-01 | 0.002 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.962032e-01 | 0.002 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.962625e-01 | 0.002 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.962811e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.963597e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.963597e-01 | 0.002 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.963942e-01 | 0.002 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.964674e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.967076e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.967076e-01 | 0.001 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.967436e-01 | 0.001 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.967436e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.968546e-01 | 0.001 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.968809e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.973069e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.973069e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.973069e-01 | 0.001 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.974969e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.975235e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.977204e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.977204e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.977972e-01 | 0.001 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.979390e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.981163e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.981703e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.981983e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.982786e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.982786e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.982786e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.982786e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.983706e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.984969e-01 | 0.001 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.986186e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.986873e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.988402e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.989048e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.989100e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.989100e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.989100e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.990143e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.990143e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990143e-01 | 0.000 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.992602e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.993050e-01 | 0.000 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.993050e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.993657e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.994446e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.994549e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.994608e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.994608e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.994716e-01 | 0.000 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.994858e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.995149e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.995178e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.995337e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.995782e-01 | 0.000 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.995783e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.995809e-01 | 0.000 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.995921e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.996149e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996394e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.996394e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.996394e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996394e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996394e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.996447e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.996953e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997221e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997334e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997466e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.997589e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.997589e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997651e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997893e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.998217e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998388e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.998403e-01 | 0.000 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.998403e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.998611e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.998611e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998673e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998682e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.998944e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.999173e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999280e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.999362e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999425e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999477e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999518e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999574e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999605e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999672e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999678e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999737e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999813e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999841e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999894e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999920e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999932e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999938e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999939e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999943e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999953e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999965e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999979e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999981e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999987e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999989e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999992e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999992e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.884981e-15 | 14.311 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.459455e-13 | 12.461 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.137068e-12 | 11.670 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.289253e-10 | 9.640 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.202747e-08 | 7.494 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.858475e-08 | 7.053 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.871664e-07 | 6.542 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.184564e-06 | 5.497 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.981855e-06 | 5.223 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.336148e-05 | 4.874 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.380639e-05 | 4.860 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.196478e-05 | 4.658 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.196478e-05 | 4.658 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.208644e-05 | 4.207 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.079882e-04 | 3.967 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.640719e-04 | 3.785 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.735114e-04 | 3.761 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.765824e-04 | 3.753 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.070715e-04 | 3.684 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.227808e-04 | 3.491 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.634610e-04 | 3.178 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.230346e-04 | 3.141 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.075771e-04 | 3.042 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.113290e-03 | 2.953 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.272973e-03 | 2.895 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.249020e-03 | 2.903 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.330145e-03 | 2.876 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.418291e-03 | 2.848 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.495492e-03 | 2.825 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.591085e-03 | 2.798 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.591085e-03 | 2.798 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.646647e-03 | 2.783 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.692448e-03 | 2.771 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.961031e-03 | 2.708 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.185255e-03 | 2.660 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.220725e-03 | 2.654 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.213037e-03 | 2.655 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.277120e-03 | 2.643 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.205437e-03 | 2.657 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.132116e-03 | 2.671 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.450578e-03 | 2.611 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.384551e-03 | 2.623 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.585336e-03 | 2.587 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.555406e-03 | 2.593 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.847013e-03 | 2.546 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.850744e-03 | 2.545 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.900716e-03 | 2.537 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.996367e-03 | 2.523 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.153343e-03 | 2.501 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.153343e-03 | 2.501 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.192021e-03 | 2.496 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.434106e-03 | 2.464 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.572393e-03 | 2.340 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.698986e-03 | 2.328 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.024056e-03 | 2.299 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.736602e-03 | 2.241 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.329587e-03 | 2.199 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.085365e-03 | 2.216 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.242855e-03 | 2.205 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.426831e-03 | 2.026 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.426831e-03 | 2.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.426831e-03 | 2.026 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 9.426831e-03 | 2.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.426831e-03 | 2.026 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.426831e-03 | 2.026 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.331238e-03 | 2.030 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.763146e-03 | 2.057 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.748626e-03 | 2.011 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.033695e-02 | 1.986 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.173803e-02 | 1.930 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.173803e-02 | 1.930 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.103881e-02 | 1.957 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.219572e-02 | 1.914 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.253028e-02 | 1.902 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.375784e-02 | 1.861 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.305466e-02 | 1.884 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.299530e-02 | 1.886 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.468728e-02 | 1.833 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.468728e-02 | 1.833 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.529299e-02 | 1.816 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.636878e-02 | 1.786 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.625192e-02 | 1.789 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.751499e-02 | 1.757 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.751865e-02 | 1.756 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.080488e-02 | 1.682 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.910502e-02 | 1.719 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.003996e-02 | 1.698 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.808126e-02 | 1.743 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.808126e-02 | 1.743 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.111498e-02 | 1.675 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.111498e-02 | 1.675 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.080488e-02 | 1.682 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.023210e-02 | 1.694 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.106935e-02 | 1.676 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.980286e-02 | 1.703 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.956719e-02 | 1.708 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.003996e-02 | 1.698 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.796645e-02 | 1.746 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.952956e-02 | 1.709 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.933702e-02 | 1.714 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.956719e-02 | 1.708 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.217746e-02 | 1.654 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.239984e-02 | 1.650 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.416612e-02 | 1.617 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.424026e-02 | 1.615 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.463688e-02 | 1.608 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.463688e-02 | 1.608 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.811652e-02 | 1.551 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.972758e-02 | 1.527 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.972758e-02 | 1.527 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.972758e-02 | 1.527 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.770923e-02 | 1.557 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.800456e-02 | 1.553 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.972758e-02 | 1.527 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.847557e-02 | 1.546 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.010913e-02 | 1.521 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.103152e-02 | 1.508 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.149310e-02 | 1.502 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.685566e-02 | 1.433 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.634862e-02 | 1.440 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.355338e-02 | 1.474 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.461095e-02 | 1.461 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.718190e-02 | 1.430 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.547627e-02 | 1.450 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.871209e-02 | 1.412 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.871209e-02 | 1.412 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.145619e-02 | 1.382 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.525017e-02 | 1.344 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.118078e-02 | 1.291 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.118078e-02 | 1.291 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.118078e-02 | 1.291 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.627726e-02 | 1.335 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.073598e-02 | 1.295 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.118078e-02 | 1.291 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.695300e-02 | 1.328 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.767837e-02 | 1.322 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.076953e-02 | 1.294 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.895849e-02 | 1.310 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.161800e-02 | 1.287 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.224486e-02 | 1.282 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.287041e-02 | 1.277 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.404294e-02 | 1.267 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.416450e-02 | 1.266 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.473729e-02 | 1.262 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.588681e-02 | 1.253 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.656466e-02 | 1.247 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.974400e-02 | 1.224 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.126485e-02 | 1.213 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 6.950493e-02 | 1.158 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 7.036352e-02 | 1.153 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.036352e-02 | 1.153 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.036352e-02 | 1.153 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 7.036352e-02 | 1.153 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.817554e-02 | 1.166 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.618301e-02 | 1.179 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.713100e-02 | 1.173 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.570106e-02 | 1.182 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.892104e-02 | 1.162 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.179543e-02 | 1.209 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.817554e-02 | 1.166 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.196045e-02 | 1.208 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.892104e-02 | 1.162 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.047476e-02 | 1.152 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.219650e-02 | 1.141 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.311486e-02 | 1.136 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.316921e-02 | 1.136 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.593804e-02 | 1.120 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.699110e-02 | 1.114 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.772216e-02 | 1.109 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.805180e-02 | 1.108 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.805180e-02 | 1.108 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.904656e-02 | 1.102 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.129612e-02 | 1.090 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.235383e-02 | 1.084 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.415727e-02 | 1.075 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.557904e-02 | 1.068 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.557904e-02 | 1.068 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.582247e-02 | 1.066 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 9.146396e-02 | 1.039 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.199926e-02 | 1.036 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.741051e-02 | 1.011 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.087043e-01 | 0.964 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.016917e-01 | 0.993 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.057756e-01 | 0.976 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.707844e-02 | 1.013 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 9.561203e-02 | 1.019 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.712956e-02 | 1.013 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.341828e-01 | 0.872 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.341828e-01 | 0.872 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.943686e-01 | 0.711 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.943686e-01 | 0.711 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.943686e-01 | 0.711 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.503740e-01 | 0.601 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.503740e-01 | 0.601 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.503740e-01 | 0.601 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.503740e-01 | 0.601 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.503740e-01 | 0.601 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.503740e-01 | 0.601 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.503740e-01 | 0.601 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.628828e-01 | 0.788 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.628828e-01 | 0.788 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.628828e-01 | 0.788 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.024892e-01 | 0.519 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.024892e-01 | 0.519 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.103072e-01 | 0.957 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.884527e-01 | 0.725 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.884527e-01 | 0.725 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.145147e-01 | 0.669 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.509842e-01 | 0.455 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.509842e-01 | 0.455 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.509842e-01 | 0.455 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.509842e-01 | 0.455 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.408771e-01 | 0.618 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.329319e-01 | 0.876 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.673722e-01 | 0.573 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.673722e-01 | 0.573 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.673722e-01 | 0.573 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.673722e-01 | 0.573 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.961102e-01 | 0.402 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.961102e-01 | 0.402 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.214095e-01 | 0.916 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.317531e-01 | 0.880 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.317531e-01 | 0.880 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.938546e-01 | 0.532 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.938546e-01 | 0.532 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.938546e-01 | 0.532 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.313634e-01 | 0.636 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.535672e-01 | 0.814 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.201979e-01 | 0.495 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.201979e-01 | 0.495 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.201979e-01 | 0.495 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.201979e-01 | 0.495 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.201979e-01 | 0.495 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.201979e-01 | 0.495 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.201979e-01 | 0.495 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.381011e-01 | 0.358 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.381011e-01 | 0.358 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.381011e-01 | 0.358 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.163918e-01 | 0.665 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.163918e-01 | 0.665 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.695802e-01 | 0.569 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.888277e-01 | 0.724 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.315057e-01 | 0.635 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.315057e-01 | 0.635 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.315057e-01 | 0.635 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.315057e-01 | 0.635 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.462938e-01 | 0.461 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.011784e-01 | 0.696 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.468680e-01 | 0.608 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.137925e-01 | 0.670 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.771746e-01 | 0.321 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.771746e-01 | 0.321 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.771746e-01 | 0.321 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.771746e-01 | 0.321 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.129307e-01 | 0.947 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.279330e-01 | 0.484 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.279330e-01 | 0.484 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.279330e-01 | 0.484 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.940960e-01 | 0.532 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.973858e-01 | 0.401 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 3.973858e-01 | 0.401 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.125576e-01 | 0.673 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.125576e-01 | 0.673 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.474333e-01 | 0.459 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.474333e-01 | 0.459 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.800529e-01 | 0.553 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.824881e-01 | 0.739 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.567864e-01 | 0.805 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.668188e-01 | 0.574 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.261962e-01 | 0.487 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.222371e-01 | 0.374 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.135331e-01 | 0.289 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.135331e-01 | 0.289 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.135331e-01 | 0.289 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.135331e-01 | 0.289 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.135331e-01 | 0.289 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.135331e-01 | 0.289 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.332314e-01 | 0.632 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.544618e-01 | 0.594 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.544618e-01 | 0.594 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.789181e-01 | 0.555 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.789181e-01 | 0.555 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.423351e-01 | 0.466 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.050502e-01 | 0.688 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.527728e-01 | 0.597 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.503013e-01 | 0.602 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.873521e-01 | 0.542 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.054096e-01 | 0.392 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.496393e-01 | 0.456 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.496393e-01 | 0.456 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.496393e-01 | 0.456 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.244238e-01 | 0.372 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.244238e-01 | 0.372 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 5.473652e-01 | 0.262 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.473652e-01 | 0.262 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.473652e-01 | 0.262 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.432228e-01 | 0.353 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.933788e-01 | 0.307 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.617759e-01 | 0.336 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.386385e-01 | 0.358 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.386385e-01 | 0.358 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.199977e-01 | 0.377 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.800555e-01 | 0.319 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.800555e-01 | 0.319 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.158338e-01 | 0.287 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.788463e-01 | 0.237 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.788463e-01 | 0.237 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.788463e-01 | 0.237 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.994202e-01 | 0.399 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.478496e-01 | 0.349 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.853679e-01 | 0.314 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.081396e-01 | 0.216 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.158426e-01 | 0.287 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.593944e-01 | 0.252 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.988176e-01 | 0.223 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.353971e-01 | 0.197 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.986263e-01 | 0.223 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.986263e-01 | 0.223 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.607600e-01 | 0.180 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.607600e-01 | 0.180 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.578874e-01 | 0.182 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.578874e-01 | 0.182 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.390824e-01 | 0.194 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.077089e-01 | 0.216 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.011784e-01 | 0.696 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.665852e-01 | 0.247 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.974840e-01 | 0.527 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.057407e-01 | 0.218 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.386385e-01 | 0.358 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.086830e-01 | 0.681 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.169528e-01 | 0.499 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.933788e-01 | 0.307 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.214095e-01 | 0.916 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.587157e-01 | 0.253 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.397568e-01 | 0.855 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.617759e-01 | 0.336 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.334223e-01 | 0.632 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.386385e-01 | 0.358 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.937042e-01 | 0.307 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.763423e-01 | 0.754 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.504081e-01 | 0.187 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.624435e-01 | 0.581 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.940960e-01 | 0.532 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.386385e-01 | 0.358 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.665852e-01 | 0.247 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.386385e-01 | 0.358 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.718108e-01 | 0.566 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.214095e-01 | 0.916 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.915857e-01 | 0.308 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.400045e-01 | 0.194 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.462938e-01 | 0.461 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.954676e-01 | 0.305 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.015621e-01 | 0.696 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.800529e-01 | 0.553 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.465482e-01 | 0.350 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.629221e-01 | 0.250 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.408771e-01 | 0.618 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.458042e-01 | 0.836 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.940960e-01 | 0.532 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.222371e-01 | 0.374 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.627323e-01 | 0.580 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.702742e-01 | 0.328 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.227783e-01 | 0.374 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.376179e-01 | 0.270 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.353971e-01 | 0.197 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.830551e-01 | 0.234 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.829856e-01 | 0.548 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.076008e-01 | 0.683 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.496393e-01 | 0.456 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.986263e-01 | 0.223 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.787202e-01 | 0.422 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.666380e-01 | 0.574 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.942831e-01 | 0.712 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.313634e-01 | 0.636 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.273610e-01 | 0.895 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.201979e-01 | 0.495 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.381011e-01 | 0.358 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.468680e-01 | 0.608 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.474333e-01 | 0.459 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.355827e-01 | 0.474 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.355827e-01 | 0.474 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.473652e-01 | 0.262 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.788463e-01 | 0.237 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.980368e-01 | 0.303 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.481580e-01 | 0.349 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.081396e-01 | 0.216 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.969811e-01 | 0.304 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.986263e-01 | 0.223 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.361131e-01 | 0.196 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.154429e-01 | 0.938 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.919120e-01 | 0.407 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.201979e-01 | 0.495 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.268536e-01 | 0.897 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.244238e-01 | 0.372 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.270689e-01 | 0.370 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.607600e-01 | 0.180 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.535509e-01 | 0.452 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.313634e-01 | 0.636 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.141233e-01 | 0.943 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.673722e-01 | 0.573 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.961102e-01 | 0.402 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.201979e-01 | 0.495 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.788463e-01 | 0.237 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.697043e-01 | 0.432 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.587157e-01 | 0.253 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.436865e-01 | 0.191 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.874253e-01 | 0.727 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.156983e-01 | 0.288 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.884527e-01 | 0.725 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.145147e-01 | 0.669 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.961102e-01 | 0.402 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.381011e-01 | 0.358 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.381011e-01 | 0.358 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.771746e-01 | 0.321 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.771746e-01 | 0.321 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.279330e-01 | 0.484 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.489822e-01 | 0.827 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.135331e-01 | 0.289 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.034676e-01 | 0.518 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.702742e-01 | 0.328 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.788463e-01 | 0.237 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.015912e-01 | 0.696 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.081396e-01 | 0.216 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.464866e-01 | 0.834 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.273610e-01 | 0.895 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.273610e-01 | 0.895 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.432228e-01 | 0.353 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.617759e-01 | 0.336 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.665852e-01 | 0.247 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.828013e-01 | 0.234 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.788463e-01 | 0.237 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.718108e-01 | 0.566 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.300165e-01 | 0.481 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.077089e-01 | 0.216 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.933788e-01 | 0.307 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.330208e-01 | 0.273 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.597847e-01 | 0.181 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.341828e-01 | 0.872 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.943686e-01 | 0.711 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.943686e-01 | 0.711 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.943686e-01 | 0.711 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.503740e-01 | 0.601 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.024892e-01 | 0.519 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.258042e-01 | 0.900 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.408771e-01 | 0.618 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 2.673722e-01 | 0.573 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.961102e-01 | 0.402 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.961102e-01 | 0.402 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.938546e-01 | 0.532 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.938546e-01 | 0.532 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.313634e-01 | 0.636 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.273610e-01 | 0.895 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.381011e-01 | 0.358 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.227917e-01 | 0.652 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.331943e-01 | 0.632 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.355827e-01 | 0.474 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.473652e-01 | 0.262 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.473652e-01 | 0.262 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.933788e-01 | 0.307 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.787202e-01 | 0.422 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.291644e-01 | 0.483 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.339607e-01 | 0.363 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.158338e-01 | 0.287 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.788463e-01 | 0.237 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.788463e-01 | 0.237 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.081396e-01 | 0.216 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.081396e-01 | 0.216 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.499878e-01 | 0.260 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.278037e-01 | 0.278 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.791174e-01 | 0.237 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.791174e-01 | 0.237 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.665852e-01 | 0.247 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.607600e-01 | 0.180 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.607600e-01 | 0.180 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.775299e-01 | 0.557 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.339716e-01 | 0.198 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.828013e-01 | 0.234 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.933788e-01 | 0.307 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.469656e-01 | 0.262 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.688837e-01 | 0.570 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.408771e-01 | 0.618 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.409438e-01 | 0.467 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.973858e-01 | 0.401 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.158338e-01 | 0.287 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.361131e-01 | 0.196 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.178154e-01 | 0.209 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.544268e-01 | 0.594 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.578874e-01 | 0.182 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.520600e-01 | 0.453 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.103136e-01 | 0.508 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.147752e-01 | 0.668 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.138869e-01 | 0.944 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.889530e-01 | 0.539 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.961102e-01 | 0.402 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.889530e-01 | 0.539 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.720493e-01 | 0.429 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.960172e-01 | 0.529 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.063433e-01 | 0.391 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.973858e-01 | 0.401 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.232918e-01 | 0.651 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.933788e-01 | 0.307 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.077603e-01 | 0.216 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.444468e-01 | 0.840 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.140702e-01 | 0.503 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.699523e-01 | 0.328 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.629221e-01 | 0.250 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.437547e-01 | 0.613 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.820775e-01 | 0.740 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.650016e-01 | 0.783 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.373990e-01 | 0.862 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.135331e-01 | 0.289 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.788463e-01 | 0.237 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.788463e-01 | 0.237 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.158426e-01 | 0.287 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.543698e-01 | 0.343 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.215368e-01 | 0.915 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.011784e-01 | 0.696 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.828013e-01 | 0.234 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.313206e-01 | 0.200 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.159975e-01 | 0.210 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.870526e-01 | 0.728 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.011784e-01 | 0.696 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.788463e-01 | 0.237 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.701707e-01 | 0.328 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.728191e-01 | 0.564 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.465482e-01 | 0.350 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.564607e-01 | 0.448 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.390824e-01 | 0.194 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.658949e-01 | 0.780 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.868087e-01 | 0.729 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.140525e-01 | 0.212 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.345845e-01 | 0.272 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.575151e-01 | 0.803 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.593944e-01 | 0.252 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.258152e-01 | 0.204 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.146347e-01 | 0.941 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.108620e-01 | 0.292 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.943686e-01 | 0.711 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 1.943686e-01 | 0.711 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.024892e-01 | 0.519 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.258042e-01 | 0.900 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.145147e-01 | 0.669 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.145147e-01 | 0.669 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.145147e-01 | 0.669 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 3.509842e-01 | 0.455 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.509842e-01 | 0.455 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.381011e-01 | 0.358 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.771746e-01 | 0.321 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.937897e-01 | 0.532 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.135331e-01 | 0.289 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.911394e-01 | 0.536 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.473652e-01 | 0.262 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.788463e-01 | 0.237 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.980368e-01 | 0.303 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.278098e-01 | 0.484 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.330208e-01 | 0.273 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.081396e-01 | 0.216 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.081396e-01 | 0.216 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.258633e-01 | 0.279 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.353971e-01 | 0.197 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.361131e-01 | 0.196 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.607600e-01 | 0.180 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.005007e-01 | 0.397 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.920359e-01 | 0.228 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.145342e-01 | 0.941 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.400045e-01 | 0.194 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.549447e-01 | 0.256 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.232369e-01 | 0.651 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.778227e-01 | 0.423 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.081396e-01 | 0.216 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.695802e-01 | 0.569 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.270689e-01 | 0.370 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.178154e-01 | 0.209 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.607600e-01 | 0.180 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.549447e-01 | 0.256 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.440564e-01 | 0.463 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.544618e-01 | 0.594 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.795880e-01 | 0.319 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.771746e-01 | 0.321 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.902454e-01 | 0.721 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.081396e-01 | 0.216 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.546835e-01 | 0.256 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.374257e-01 | 0.862 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.133374e-01 | 0.504 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.133374e-01 | 0.504 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.260438e-01 | 0.279 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.178154e-01 | 0.209 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.156314e-01 | 0.288 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.134701e-01 | 0.504 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.068954e-01 | 0.391 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.665852e-01 | 0.247 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.391852e-01 | 0.856 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.193039e-01 | 0.285 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.503740e-01 | 0.601 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.628828e-01 | 0.788 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.628828e-01 | 0.788 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.509842e-01 | 0.455 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.673722e-01 | 0.573 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.961102e-01 | 0.402 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.468680e-01 | 0.608 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.771746e-01 | 0.321 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.279330e-01 | 0.484 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.664487e-01 | 0.574 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.135331e-01 | 0.289 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.135331e-01 | 0.289 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.728211e-01 | 0.762 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.473652e-01 | 0.262 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.473652e-01 | 0.262 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.227783e-01 | 0.374 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.788463e-01 | 0.237 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.272607e-01 | 0.203 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.436865e-01 | 0.191 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 6.537161e-01 | 0.185 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.100222e-01 | 0.215 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.587157e-01 | 0.253 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.272607e-01 | 0.203 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.986263e-01 | 0.223 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.236664e-01 | 0.650 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.728993e-01 | 0.762 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.728993e-01 | 0.762 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.434744e-01 | 0.614 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.820815e-01 | 0.317 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.591381e-01 | 0.798 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.499878e-01 | 0.260 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.607600e-01 | 0.180 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.276480e-01 | 0.202 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.036265e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.145147e-01 | 0.669 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.054096e-01 | 0.392 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.140525e-01 | 0.212 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.469400e-01 | 0.262 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.787202e-01 | 0.422 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.358993e-01 | 0.271 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.158338e-01 | 0.287 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.163918e-01 | 0.665 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.329319e-01 | 0.876 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.961102e-01 | 0.402 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.938546e-01 | 0.532 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.424781e-01 | 0.846 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.381011e-01 | 0.358 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.973858e-01 | 0.401 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.973858e-01 | 0.401 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.135331e-01 | 0.289 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.496393e-01 | 0.456 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.788463e-01 | 0.237 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.788463e-01 | 0.237 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.353971e-01 | 0.197 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.010785e-01 | 0.221 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.973858e-01 | 0.401 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.190356e-01 | 0.378 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.504081e-01 | 0.187 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.496393e-01 | 0.456 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.324302e-01 | 0.634 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.329319e-01 | 0.876 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 5.788463e-01 | 0.237 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.081396e-01 | 0.216 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.499878e-01 | 0.260 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 6.537161e-01 | 0.185 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.492175e-01 | 0.348 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.695802e-01 | 0.569 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.376179e-01 | 0.270 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.081396e-01 | 0.216 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.871073e-01 | 0.312 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.973858e-01 | 0.401 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.473652e-01 | 0.262 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.227783e-01 | 0.374 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.353971e-01 | 0.197 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.140525e-01 | 0.212 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.158338e-01 | 0.287 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.548254e-01 | 0.342 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.746432e-01 | 0.426 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.081396e-01 | 0.216 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.222371e-01 | 0.374 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.288538e-01 | 0.277 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.612897e-01 | 0.792 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.465482e-01 | 0.350 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.587157e-01 | 0.253 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.499878e-01 | 0.260 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.533721e-01 | 0.814 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.408771e-01 | 0.618 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.702742e-01 | 0.328 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.988176e-01 | 0.223 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.353971e-01 | 0.197 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.462938e-01 | 0.461 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.290739e-01 | 0.201 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.979282e-01 | 0.703 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.408632e-01 | 0.618 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.403449e-01 | 0.619 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.791174e-01 | 0.237 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.591602e-01 | 0.181 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.853679e-01 | 0.314 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.595394e-01 | 0.586 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.862143e-01 | 0.413 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.627323e-01 | 0.580 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.537161e-01 | 0.185 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 3.961102e-01 | 0.402 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.178154e-01 | 0.209 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.612878e-01 | 0.180 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.612878e-01 | 0.180 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.671217e-01 | 0.176 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.706325e-01 | 0.174 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.706325e-01 | 0.174 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.720527e-01 | 0.173 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.764947e-01 | 0.170 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.764947e-01 | 0.170 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.795795e-01 | 0.168 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.825891e-01 | 0.166 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.825891e-01 | 0.166 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.843601e-01 | 0.165 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.843601e-01 | 0.165 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.843601e-01 | 0.165 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.843601e-01 | 0.165 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.843601e-01 | 0.165 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.843601e-01 | 0.165 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.843601e-01 | 0.165 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.843601e-01 | 0.165 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.843601e-01 | 0.165 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.843601e-01 | 0.165 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.843601e-01 | 0.165 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 6.843601e-01 | 0.165 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.843601e-01 | 0.165 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.843601e-01 | 0.165 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.843601e-01 | 0.165 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.843601e-01 | 0.165 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.843601e-01 | 0.165 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.850508e-01 | 0.164 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.850508e-01 | 0.164 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.850508e-01 | 0.164 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.850508e-01 | 0.164 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.850508e-01 | 0.164 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.868727e-01 | 0.163 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.868727e-01 | 0.163 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 6.868727e-01 | 0.163 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.868727e-01 | 0.163 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.904414e-01 | 0.161 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.928955e-01 | 0.159 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.934429e-01 | 0.159 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.937710e-01 | 0.159 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.950181e-01 | 0.158 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.972486e-01 | 0.157 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.980147e-01 | 0.156 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.984644e-01 | 0.156 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.024489e-01 | 0.153 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.024489e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.029705e-01 | 0.153 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.063197e-01 | 0.151 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.063197e-01 | 0.151 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.063197e-01 | 0.151 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.063197e-01 | 0.151 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.063197e-01 | 0.151 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.063197e-01 | 0.151 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.063197e-01 | 0.151 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.063197e-01 | 0.151 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.063197e-01 | 0.151 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.063197e-01 | 0.151 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.063197e-01 | 0.151 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.063197e-01 | 0.151 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.063197e-01 | 0.151 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.063197e-01 | 0.151 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.063197e-01 | 0.151 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.077092e-01 | 0.150 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.084853e-01 | 0.150 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.102269e-01 | 0.149 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.103312e-01 | 0.149 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.105694e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.105694e-01 | 0.148 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.105694e-01 | 0.148 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.105694e-01 | 0.148 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.128134e-01 | 0.147 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.128134e-01 | 0.147 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.173747e-01 | 0.144 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.173747e-01 | 0.144 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.210167e-01 | 0.142 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.210179e-01 | 0.142 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.210179e-01 | 0.142 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.210179e-01 | 0.142 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.210179e-01 | 0.142 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.210179e-01 | 0.142 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.210179e-01 | 0.142 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.267527e-01 | 0.139 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.267527e-01 | 0.139 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.267527e-01 | 0.139 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.267527e-01 | 0.139 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.267527e-01 | 0.139 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.267527e-01 | 0.139 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.267527e-01 | 0.139 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.267527e-01 | 0.139 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.267527e-01 | 0.139 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.314098e-01 | 0.136 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.316654e-01 | 0.136 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.316654e-01 | 0.136 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.316654e-01 | 0.136 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.316654e-01 | 0.136 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.344656e-01 | 0.134 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.344656e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.344656e-01 | 0.134 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.344656e-01 | 0.134 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.344656e-01 | 0.134 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.377476e-01 | 0.132 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.409478e-01 | 0.130 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.415085e-01 | 0.130 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.446912e-01 | 0.128 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.453369e-01 | 0.128 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.457652e-01 | 0.127 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.457652e-01 | 0.127 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.457652e-01 | 0.127 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.457652e-01 | 0.127 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.457652e-01 | 0.127 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.457652e-01 | 0.127 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.457652e-01 | 0.127 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.457652e-01 | 0.127 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.458162e-01 | 0.127 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.505388e-01 | 0.125 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.513162e-01 | 0.124 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.513162e-01 | 0.124 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.524427e-01 | 0.124 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.585475e-01 | 0.120 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.585476e-01 | 0.120 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.608355e-01 | 0.119 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.608355e-01 | 0.119 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.615933e-01 | 0.118 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.634559e-01 | 0.117 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.634559e-01 | 0.117 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.634559e-01 | 0.117 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.634559e-01 | 0.117 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.634559e-01 | 0.117 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.634559e-01 | 0.117 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.634559e-01 | 0.117 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.634559e-01 | 0.117 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.634559e-01 | 0.117 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.634559e-01 | 0.117 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 7.634559e-01 | 0.117 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.673510e-01 | 0.115 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.700694e-01 | 0.113 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.700694e-01 | 0.113 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.708910e-01 | 0.113 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.708910e-01 | 0.113 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.708910e-01 | 0.113 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.708910e-01 | 0.113 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.708910e-01 | 0.113 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.708910e-01 | 0.113 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.725711e-01 | 0.112 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.775482e-01 | 0.109 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.799166e-01 | 0.108 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.799166e-01 | 0.108 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.799166e-01 | 0.108 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.799166e-01 | 0.108 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.799166e-01 | 0.108 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.799166e-01 | 0.108 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.799166e-01 | 0.108 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.799166e-01 | 0.108 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.799166e-01 | 0.108 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.799166e-01 | 0.108 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.813473e-01 | 0.107 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.814360e-01 | 0.107 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.823994e-01 | 0.107 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.828093e-01 | 0.106 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.828093e-01 | 0.106 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.873748e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.873748e-01 | 0.104 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.873748e-01 | 0.104 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.885274e-01 | 0.103 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.910211e-01 | 0.102 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.941794e-01 | 0.100 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.941794e-01 | 0.100 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.941794e-01 | 0.100 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.941794e-01 | 0.100 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.941794e-01 | 0.100 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.952328e-01 | 0.100 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.952328e-01 | 0.100 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.952328e-01 | 0.100 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.952328e-01 | 0.100 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.952328e-01 | 0.100 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.952328e-01 | 0.100 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.952328e-01 | 0.100 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.952328e-01 | 0.100 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.952328e-01 | 0.100 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.952328e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.957594e-01 | 0.099 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.985839e-01 | 0.098 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.042240e-01 | 0.095 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.050198e-01 | 0.094 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.050198e-01 | 0.094 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.050198e-01 | 0.094 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.059294e-01 | 0.094 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.059476e-01 | 0.094 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.059476e-01 | 0.094 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.059476e-01 | 0.094 | 0 | 0 |
| Translation | R-HSA-72766 | 8.078082e-01 | 0.093 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.094839e-01 | 0.092 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.094839e-01 | 0.092 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.094839e-01 | 0.092 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.094839e-01 | 0.092 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.094839e-01 | 0.092 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.094839e-01 | 0.092 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.094839e-01 | 0.092 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.094839e-01 | 0.092 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.094839e-01 | 0.092 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.120883e-01 | 0.090 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.127265e-01 | 0.090 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.153492e-01 | 0.089 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.153492e-01 | 0.089 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.153492e-01 | 0.089 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.153492e-01 | 0.089 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.184613e-01 | 0.087 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.196923e-01 | 0.086 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.206335e-01 | 0.086 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.227440e-01 | 0.085 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.227440e-01 | 0.085 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.227440e-01 | 0.085 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.227440e-01 | 0.085 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.227440e-01 | 0.085 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.227440e-01 | 0.085 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.227440e-01 | 0.085 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.227440e-01 | 0.085 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.227440e-01 | 0.085 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.251863e-01 | 0.083 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.251863e-01 | 0.083 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.251863e-01 | 0.083 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.251863e-01 | 0.083 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.251863e-01 | 0.083 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.343964e-01 | 0.079 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.345494e-01 | 0.079 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.350819e-01 | 0.078 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.350819e-01 | 0.078 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.350819e-01 | 0.078 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.350819e-01 | 0.078 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.350819e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.390048e-01 | 0.076 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.390048e-01 | 0.076 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.390048e-01 | 0.076 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.402274e-01 | 0.076 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.402274e-01 | 0.076 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.409454e-01 | 0.075 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.409927e-01 | 0.075 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.434568e-01 | 0.074 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.464683e-01 | 0.072 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.464683e-01 | 0.072 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.465617e-01 | 0.072 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.465617e-01 | 0.072 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.465617e-01 | 0.072 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.465617e-01 | 0.072 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.465617e-01 | 0.072 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.465617e-01 | 0.072 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.465617e-01 | 0.072 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.519267e-01 | 0.070 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.519267e-01 | 0.070 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.529082e-01 | 0.069 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.536292e-01 | 0.069 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.536292e-01 | 0.069 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.572430e-01 | 0.067 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.572430e-01 | 0.067 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.572430e-01 | 0.067 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.572430e-01 | 0.067 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.572430e-01 | 0.067 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.572430e-01 | 0.067 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.572430e-01 | 0.067 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.572430e-01 | 0.067 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.599766e-01 | 0.066 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.599766e-01 | 0.066 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.599766e-01 | 0.066 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.599766e-01 | 0.066 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.604968e-01 | 0.065 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.624734e-01 | 0.064 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.660673e-01 | 0.062 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.669315e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.671814e-01 | 0.062 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.671814e-01 | 0.062 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.671814e-01 | 0.062 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.671814e-01 | 0.062 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.671814e-01 | 0.062 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.671814e-01 | 0.062 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.671814e-01 | 0.062 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.671814e-01 | 0.062 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.671814e-01 | 0.062 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.676242e-01 | 0.062 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.676242e-01 | 0.062 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.676242e-01 | 0.062 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.676242e-01 | 0.062 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.676242e-01 | 0.062 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.681638e-01 | 0.061 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.684071e-01 | 0.061 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.717792e-01 | 0.060 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.725473e-01 | 0.059 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.733876e-01 | 0.059 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.733876e-01 | 0.059 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.740932e-01 | 0.058 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.748862e-01 | 0.058 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.748862e-01 | 0.058 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.764285e-01 | 0.057 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.764285e-01 | 0.057 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.764285e-01 | 0.057 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.794288e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.794288e-01 | 0.056 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.794288e-01 | 0.056 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.794288e-01 | 0.056 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.817793e-01 | 0.055 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.817793e-01 | 0.055 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.850322e-01 | 0.053 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.850322e-01 | 0.053 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.850322e-01 | 0.053 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.852123e-01 | 0.053 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.852123e-01 | 0.053 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.878650e-01 | 0.052 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.883197e-01 | 0.051 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.883197e-01 | 0.051 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.883197e-01 | 0.051 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.923764e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.930375e-01 | 0.049 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.930375e-01 | 0.049 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.930375e-01 | 0.049 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.930375e-01 | 0.049 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.930375e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.930375e-01 | 0.049 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.930375e-01 | 0.049 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.930375e-01 | 0.049 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.930375e-01 | 0.049 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.945230e-01 | 0.048 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.945230e-01 | 0.048 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.945230e-01 | 0.048 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.952596e-01 | 0.048 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.967303e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.979899e-01 | 0.047 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.002944e-01 | 0.046 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.004045e-01 | 0.046 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.004045e-01 | 0.046 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.004045e-01 | 0.046 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.004045e-01 | 0.046 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.004857e-01 | 0.046 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.004857e-01 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.004857e-01 | 0.046 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.004857e-01 | 0.046 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.004857e-01 | 0.046 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.004857e-01 | 0.046 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.004857e-01 | 0.046 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.049822e-01 | 0.043 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.059789e-01 | 0.043 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.059789e-01 | 0.043 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.059789e-01 | 0.043 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.061991e-01 | 0.043 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.074157e-01 | 0.042 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.074157e-01 | 0.042 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.074157e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.074157e-01 | 0.042 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.074157e-01 | 0.042 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.074157e-01 | 0.042 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.074157e-01 | 0.042 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.074157e-01 | 0.042 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.103459e-01 | 0.041 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.105660e-01 | 0.041 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.112603e-01 | 0.040 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.112603e-01 | 0.040 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.127003e-01 | 0.040 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.138635e-01 | 0.039 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.138635e-01 | 0.039 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.138635e-01 | 0.039 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.138635e-01 | 0.039 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.138635e-01 | 0.039 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.138635e-01 | 0.039 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.162626e-01 | 0.038 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.162626e-01 | 0.038 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.162626e-01 | 0.038 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.162626e-01 | 0.038 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.172203e-01 | 0.038 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.191991e-01 | 0.037 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.197748e-01 | 0.036 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.198627e-01 | 0.036 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.198627e-01 | 0.036 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.198627e-01 | 0.036 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.198627e-01 | 0.036 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.198627e-01 | 0.036 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.198627e-01 | 0.036 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.198627e-01 | 0.036 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.198627e-01 | 0.036 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.198627e-01 | 0.036 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.226225e-01 | 0.035 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.254443e-01 | 0.034 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.254443e-01 | 0.034 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.254443e-01 | 0.034 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.254443e-01 | 0.034 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.254443e-01 | 0.034 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.254557e-01 | 0.034 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.254822e-01 | 0.034 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.254822e-01 | 0.034 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.254822e-01 | 0.034 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.270647e-01 | 0.033 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.288563e-01 | 0.032 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.297246e-01 | 0.032 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.297246e-01 | 0.032 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.306375e-01 | 0.031 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.306375e-01 | 0.031 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.306375e-01 | 0.031 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.306375e-01 | 0.031 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.306375e-01 | 0.031 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.324946e-01 | 0.030 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.337379e-01 | 0.030 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.337379e-01 | 0.030 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.346328e-01 | 0.029 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.348630e-01 | 0.029 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.352405e-01 | 0.029 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.352405e-01 | 0.029 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.354692e-01 | 0.029 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.354692e-01 | 0.029 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.368668e-01 | 0.028 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.368668e-01 | 0.028 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.368668e-01 | 0.028 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.375334e-01 | 0.028 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.375334e-01 | 0.028 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.375521e-01 | 0.028 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.399647e-01 | 0.027 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.399647e-01 | 0.027 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.399647e-01 | 0.027 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.399647e-01 | 0.027 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.411220e-01 | 0.026 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.411220e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.411220e-01 | 0.026 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.417488e-01 | 0.026 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.434849e-01 | 0.025 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.437499e-01 | 0.025 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.437499e-01 | 0.025 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.441472e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.441472e-01 | 0.025 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.441472e-01 | 0.025 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.441472e-01 | 0.025 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.445141e-01 | 0.025 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.451960e-01 | 0.024 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.466301e-01 | 0.024 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.469619e-01 | 0.024 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.480386e-01 | 0.023 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.480386e-01 | 0.023 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.480386e-01 | 0.023 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.480386e-01 | 0.023 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.480386e-01 | 0.023 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.480386e-01 | 0.023 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.480386e-01 | 0.023 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.480386e-01 | 0.023 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.480386e-01 | 0.023 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.480386e-01 | 0.023 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.513943e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.516590e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.516590e-01 | 0.022 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.516590e-01 | 0.022 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.516590e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.516590e-01 | 0.022 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.516590e-01 | 0.022 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.536085e-01 | 0.021 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.536956e-01 | 0.021 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.536956e-01 | 0.021 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.536956e-01 | 0.021 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.547498e-01 | 0.020 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.550274e-01 | 0.020 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.550274e-01 | 0.020 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.550274e-01 | 0.020 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.553773e-01 | 0.020 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.563097e-01 | 0.019 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.568318e-01 | 0.019 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.581613e-01 | 0.019 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.581613e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.581613e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.588600e-01 | 0.018 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.588600e-01 | 0.018 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.588600e-01 | 0.018 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.590803e-01 | 0.018 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.591817e-01 | 0.018 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.608183e-01 | 0.017 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.610770e-01 | 0.017 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.610770e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.610770e-01 | 0.017 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.611987e-01 | 0.017 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.612672e-01 | 0.017 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.619316e-01 | 0.017 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.623954e-01 | 0.017 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.623954e-01 | 0.017 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.632516e-01 | 0.016 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.635933e-01 | 0.016 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.635933e-01 | 0.016 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.637896e-01 | 0.016 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.637896e-01 | 0.016 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.647105e-01 | 0.016 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.651448e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.651839e-01 | 0.015 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.653782e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.663134e-01 | 0.015 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.663134e-01 | 0.015 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.663134e-01 | 0.015 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.681445e-01 | 0.014 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.686614e-01 | 0.014 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.686614e-01 | 0.014 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.686614e-01 | 0.014 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.686614e-01 | 0.014 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.686614e-01 | 0.014 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.686614e-01 | 0.014 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.687648e-01 | 0.014 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.687909e-01 | 0.014 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.701094e-01 | 0.013 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.707077e-01 | 0.013 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.708459e-01 | 0.013 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.708459e-01 | 0.013 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.708459e-01 | 0.013 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.708459e-01 | 0.013 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.708459e-01 | 0.013 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.714094e-01 | 0.013 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.727907e-01 | 0.012 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.728782e-01 | 0.012 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.731047e-01 | 0.012 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.731587e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.734897e-01 | 0.012 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.744825e-01 | 0.011 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.747689e-01 | 0.011 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.747689e-01 | 0.011 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.757449e-01 | 0.011 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.757449e-01 | 0.011 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.757449e-01 | 0.011 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.758815e-01 | 0.011 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.762088e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.762088e-01 | 0.010 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.765280e-01 | 0.010 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.765280e-01 | 0.010 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.765280e-01 | 0.010 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.765280e-01 | 0.010 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.765280e-01 | 0.010 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.765280e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.775311e-01 | 0.010 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.775311e-01 | 0.010 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.776279e-01 | 0.010 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.776279e-01 | 0.010 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.776279e-01 | 0.010 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.780167e-01 | 0.010 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.781645e-01 | 0.010 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.781645e-01 | 0.010 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.781645e-01 | 0.010 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.781645e-01 | 0.010 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.786358e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.787427e-01 | 0.009 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.789650e-01 | 0.009 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.789650e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.790707e-01 | 0.009 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.791889e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.791889e-01 | 0.009 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.796870e-01 | 0.009 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.796870e-01 | 0.009 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.802244e-01 | 0.009 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.809816e-01 | 0.008 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.821680e-01 | 0.008 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.824212e-01 | 0.008 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.824212e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.825277e-01 | 0.008 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.829943e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.829995e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.830680e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.832609e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.836471e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.836471e-01 | 0.007 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.847876e-01 | 0.007 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.848022e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.855014e-01 | 0.006 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.858486e-01 | 0.006 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.858486e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.858486e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.862553e-01 | 0.006 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.862553e-01 | 0.006 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.862553e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.863785e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.877540e-01 | 0.005 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.877540e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.880541e-01 | 0.005 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.880541e-01 | 0.005 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.880541e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.882623e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.882623e-01 | 0.005 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.886331e-01 | 0.005 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.889719e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.892689e-01 | 0.005 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.894030e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.894030e-01 | 0.005 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.901423e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.901428e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.908301e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.910008e-01 | 0.004 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.914700e-01 | 0.004 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.923383e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.926189e-01 | 0.003 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.926189e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.926189e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.926189e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.931341e-01 | 0.003 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.931817e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.936063e-01 | 0.003 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.936133e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.938278e-01 | 0.003 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.943047e-01 | 0.002 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.944737e-01 | 0.002 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.944737e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.945939e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.952184e-01 | 0.002 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.954490e-01 | 0.002 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.955443e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.955522e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.958627e-01 | 0.002 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.961710e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.966231e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.966703e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.966703e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.966703e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.968312e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.970347e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.971191e-01 | 0.001 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.972199e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.973001e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.973203e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.975075e-01 | 0.001 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.977162e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.978218e-01 | 0.001 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.978322e-01 | 0.001 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.978931e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.979942e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.979942e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.981147e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.983445e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.983510e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.986036e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.986119e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.987244e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.990280e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.990802e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.991592e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.992180e-01 | 0.000 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.992638e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.993475e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.993475e-01 | 0.000 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.993776e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.994148e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994846e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994846e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.994938e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.995585e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.995621e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996221e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996478e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.996691e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.996982e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997365e-01 | 0.000 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.997454e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997847e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998525e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998629e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998970e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999113e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999130e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999157e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999311e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999490e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999497e-01 | 0.000 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.999694e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999760e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999827e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999842e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999866e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999870e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999922e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999938e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999955e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999965e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999972e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999974e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999980e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999986e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.999993e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999996e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |